Australia markets close in 5 hours 18 minutes

OncoSil Medical Limited (OSL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00800.0000 (0.00%)
As of 04:10PM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 26.66M
Enterprise value 21.87M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)53.34
Price/book (mrq)6.53
Enterprise value/revenue 91.40
Enterprise value/EBITDA -0.70

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3-38.46%
S&P500 52-week change 321.83%
52-week high 30.0130
52-week low 30.0040
50-day moving average 30.0057
200-day moving average 30.0071

Share statistics

Avg vol (3-month) 35.93M
Avg vol (10-day) 313.18M
Shares outstanding 53.33B
Implied shares outstanding 63.4B
Float 81.66B
% held by insiders 117.36%
% held by institutions 11.45%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-946.57%

Management effectiveness

Return on assets (ttm)-103.64%
Return on equity (ttm)-237.87%

Income statement

Revenue (ttm)1.3M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-20.90%
Gross profit (ttm)N/A
EBITDA -11.64M
Net income avi to common (ttm)-11.71M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.89M
Total cash per share (mrq)0
Total debt (mrq)107.12k
Total debt/equity (mrq)2.62%
Current ratio (mrq)2.74
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-10.22M
Levered free cash flow (ttm)-5.93M